Position in IDYA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$5,894,322
+$501,916 QoQ
Shares Held
158,152
-2.3% QoQ
Ownership
0.164%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#67
of 286 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IDYA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ROYAL BANK OF CANADA holds $2,118,794,122 across 427 Biotechnology names. IDYA ranks #28 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IONS |
Ionis Pharmaceuticals Inc
|
6,182,479 | $490,208,754 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
980,259 | $486,924,048 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
875,859 | $263,659,830 | |
| 4 | INCY |
Incyte Corp
|
1,132,050 | $128,329,182 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
174,515 | $108,817,078 | |
| 6 | MRNA |
Moderna, Inc.
|
944,457 | $66,140,319 | |
| 7 | INSM |
INSMED Inc
|
416,487 | $44,405,840 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
545,761 | $42,716,712 |
All Filings in IDYA
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,894,322 | 158,152 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $5,392,406 | 161,837 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $5,715,213 | 165,323 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $11,145,729 | 409,619 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $7,940,764 | 377,772 | Shares | Defined | 2025-11-21 | |
| 2025-03-31 | $2,005,892 | 122,460 | Shares | Defined | 2025-11-21 | |
| 2024-12-31 | $2,419,346 | 94,138 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $2,597,091 | 81,979 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $3,176,822 | 90,482 | Shares | Defined | 2024-11-06 | |
| 2024-03-31 | $2,357,407 | 53,724 | Shares | Defined | 2024-11-05 | |
| 2023-12-31 | $654,385 | 18,392 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $211,387 | 7,835 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $103,541 | 4,406 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $373,894 | 27,232 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $487,626 | 26,837 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $6,743 | 452 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $8,556 | 620 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $22,748 | 2,033 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $156,211 | 6,608 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $89,826 | 3,524 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $40,488 | 1,929 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $39,809 | 1,694 | Shares | Defined | 2021-07-20 | |
| 2020-12-31 | $14,896 | 1,064 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $301 | 24 | Shares | Defined | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||